Management of COPD in Critical Care

Initial Assessment and Management

The American Thoracic Society recommends evaluating the severity of exacerbation, including life-threatening conditions, identifying the cause, providing controlled oxygenation, and aiming to return the patient to their best previous condition 2
Admit patients with severe exacerbations to intensive care or specialized respiratory care units when adequate personnel skills and equipment exist to manage acute respiratory failure 1
Titrate supplemental oxygen to improve hypoxemia with a target saturation of 88-92% to avoid carbon dioxide retention and worsening acidosis 1
Monitor blood gases after initiating oxygen therapy to ensure satisfactory oxygenation without carbon dioxide retention 1

Administer antibiotics to patients with acute exacerbations who have three cardinal symptoms: increased dyspnea, sputum volume, and sputum purulence 1
Antibiotic therapy reduces short-term mortality by 77%, treatment failure by 53%, and sputum purulence by 44% 1
Choose antibiotics based on local bacterial resistance patterns, with typical initial empirical treatment being an aminopenicillin with clavulanic acid, a macrolide, or a tetracycline 1
Recommended duration of antibiotic therapy is 5-7 days 1

Use short-acting β2-agonists and anticholinergics for immediate symptom relief 3
Consider long-acting bronchodilators (LABAs and LAMAs) for maintenance therapy 3
For patients with persistent symptoms, combination therapy (LAMA+LABA) provides better outcomes than either agent alone 3

Administer systemic corticosteroids (oral or IV) for severe exacerbations 3
Consider inhaled corticosteroids (ICS) in addition to bronchodilator therapy for patients with frequent exacerbations 3
Monitor for increased pneumonia risk with ICS therapy 3

NIV is preferred over invasive ventilation as the initial mode of ventilation for acute respiratory failure in COPD exacerbations 1, 2
NIV reduces mortality and intubation rates with a success rate of 80-85% 1, 2
Consider NIV for patients with pronounced daytime hypercapnia and recent hospitalization 4

Initiate invasive mechanical ventilation when there is failure of an initial trial of NIV 1
Be aware that patients who fail NIV as initial therapy and receive invasive ventilation as rescue therapy experience greater morbidity, longer hospital stays, and higher mortality 1

Titrate supplemental oxygen to improve hypoxemia with a target saturation of 88-92% for COPD patients 1
Long-term oxygen therapy is indicated for stable patients with PaO2 ≤55 mm Hg or SaO2 ≤88%, with or without hypercapnia, confirmed twice over 3 weeks 4
Long-term oxygen therapy is also indicated for patients with PaO2 between 55-60 mm Hg or SaO2 of 88% if there is evidence of pulmonary hypertension, peripheral edema suggesting congestive heart failure, or polycythemia (hematocrit >55%) 4

Perform spirometric assessment and arterial blood gas analysis before discharge to reduce risk of rehospitalization and mortality 1
Consider care bundles at hospital discharge including education, medication optimization, inhaler technique correction, comorbidity management, early rehabilitation, and continued patient contact 1
Schedule early follow-up (<30 days) after discharge to reduce exacerbation-related readmissions 1
Plan additional follow-up at 3 months to ensure return to stable state and review symptoms, lung function, and assess prognosis 1

Avoid excessive oxygen administration, as this can worsen hypercapnia in COPD patients; target SpO2 88-92% rather than higher levels 1
Do not delay antibiotics in patients requiring mechanical ventilation, as this increases mortality and risk of secondary nosocomial pneumonia 1
Recognize that NIV failure requiring subsequent invasive ventilation is associated with worse outcomes than initial invasive ventilation in appropriate cases 1
Be aware that mortality in COPD exacerbations relates to patient age, presence of acidotic respiratory failure, need for ventilatory support, and comorbidities including anxiety and depression 1
Patients not attending early follow-up after discharge have increased 90-day mortality 1